The SPRINT trial suggests that markers of tubule cell function in the urine associate with risk of subsequent acute kidney injury while injury markers elevate after the injury
Alexander L. Bullen(University of California San Diego), Michelle M. Estrella(San Francisco VA Medical Center), Alexandra K. Lee(Johns Hopkins University), Ronit Katz(University of Washington), Barry M. Wall(University of Tennessee Health Science Center), Joachim H. Ix(University of San Diego), Pranav S. Garimella, Udayan Bhatt(The Ohio State University Wexner Medical Center), Chirag R. Parikh(College of Medicine & JNM Hospital), Cheryl A.M. Anderson(University of California San Diego), Alfred K. Cheung(University of Utah), James P. Lash(University of Illinois Chicago), Anjay Rastogi(University of California, Los Angeles), Michael V. Rocco(Wake Forest University), Vasantha Jotwani(San Francisco VA Medical Center), Erik Riessen(Intermountain Medical Center), Henry Punzi(Trinity Medical Center), William E. Haley(Jacksonville College), Areef Ishani(University of Minnesota), Javier A. Neyra(University of Alabama at Birmingham), Michael G. Shlipak(San Francisco VA Medical Center), Rakesh Malhotra
Cited by 66
Related Papers
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
|Data Archiving and Networked Services (DANS)|2003|2.5k
KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update
|American Journal of Kidney Diseases|2015|1.3k
Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years
|JAMA|2016|1.2k
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
|JAMA Internal Medicine|2020|1k